Abstract
Most patients with prostate cancer have disease that has extended beyond the confines of the gland at the time of diagnosis. The effect of earlier detection on morbidity and death requires further study, as does assessment of prognostic factors and optimal therapy for individual patients. Recent reports indicate the utility of using prostate specific antigen and digital rectal examination as preliminary tests to identify patients in whom further study by prostate ultrasonography will improve detection rates. The algorithm presented may be a useful guide in sequencing detection approaches. The value of mass screening for prostate cancer by any existing means remains unproven.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
